On November 21, 2025, Dogwood Therapeutics, Inc. announced that stockholders approved an increase in shares under its equity incentive plan by 2,781,665 shares, raising the total from 191,122 to 2,972,787 shares. This decision supports the conversion of Series A Non-Voting Convertible Preferred Stock and completes a business combination with Sealbond Limited.